<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">72867</article-id><article-id pub-id-type="doi">10.7554/eLife.72867</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-248794"><name><surname>Maron</surname><given-names>Maxim I</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7809-5888</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250222"><name><surname>Casill</surname><given-names>Alyssa D</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250223"><name><surname>Gupta</surname><given-names>Varun</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-261659"><name><surname>Roth</surname><given-names>Jacob S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-230204"><name><surname>Sidoli</surname><given-names>Simone</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250224"><name><surname>Query</surname><given-names>Charles C</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7692-2496</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250225"><name><surname>Gamble</surname><given-names>Matthew J</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-202430"><name><surname>Shechter</surname><given-names>David</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9388-6004</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Biochemistry</institution>, <institution>Albert Einstein College of Medicine</institution>, <addr-line><named-content content-type="city">Bronx</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Molecular Pharmacology</institution>, <institution>Albert Einstein College of Medicine</institution>, <addr-line><named-content content-type="city">Bronx</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Cell Biology</institution>, <institution>Albert Einstein College of Medicine</institution>, <addr-line><named-content content-type="city">Bronx</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-164608"><name><surname>Lynch</surname><given-names>Kristen W</given-names></name><role>Reviewing editor</role><aff><institution>University of Pennsylvania</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>david.shechter@einsteinmed.org</email> (DS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>05</day><month>01</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e72867</elocation-id><history><date date-type="received"><day>06</day><month>08</month><year>2021</year></date><date date-type="accepted"><day>03</day><month>01</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Maron et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Maron et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-72867-v1.pdf"/><abstract><p>Protein arginine methyltransferases (PRMTs) are required for the regulation of RNA processing factors. Type I PRMT enzymes catalyze mono- and asymmetric dimethylation; Type II enzymes catalyze mono- and symmetric dimethylation. To understand the specific mechanisms of PRMT activity in splicing regulation, we inhibited Type I and II PRMTs and probed their transcriptomic consequences. Using the newly developed Splicing Kinetics and Transcript Elongation Rates by Sequencing (SKaTER-seq) method, analysis of co-transcriptional splicing demonstrated that PRMT inhibition resulted in altered splicing rates. Surprisingly, co-transcriptional splicing kinetics did not correlate with final changes in splicing of polyadenylated RNA. This was particularly true for retained introns (RI). By using actinomycin D to inhibit ongoing transcription, we determined that PRMTs post-transcriptionally regulate RI. Subsequent proteomic analysis of both PRMT-inhibited chromatin and chromatin-associated polyadenylated RNA identified altered binding of many proteins, including the Type I substrate, CHTOP, and the Type II substrate, SmB. Targeted mutagenesis of all methylarginine sites in SmD3, SmB, and SmD1 recapitulated splicing changes seen with Type II PRMT inhibition, without disrupting snRNP assembly. Similarly, mutagenesis of all methylarginine sites in CHTOP recapitulated the splicing changes seen with Type I PRMT inhibition. Examination of subcellular fractions further revealed that RI were enriched in the nucleoplasm and chromatin. Together, these data demonstrate that, through Sm and CHTOP arginine methylation, PRMTs regulate the post-transcriptional processing of nuclear, detained introns.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R01GM108646</award-id><principal-award-recipient><name><surname>Shechter</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R01GM57829</award-id><principal-award-recipient><name><surname>Query</surname><given-names>Charles C</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R01GM134379</award-id><principal-award-recipient><name><surname>Gamble</surname><given-names>Matthew J</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100002590</institution-id><institution>American Lung Association</institution></institution-wrap></funding-source><award-id>LCD-564723</award-id><principal-award-recipient><name><surname>Shechter</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006984</institution-id><institution>Irma T. Hirschl Trust</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Gamble</surname><given-names>Matthew J</given-names></name><name><surname>Shechter</surname><given-names>David</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Raw data for RNA seq and SKaTER seq is deposited under GEO (GSE163421)Raw data for chromatin-associated poly(A) LC-MS/MS is deposited under Chorus (1729).All code used to generate data in this manuscript can be found here: https://github.com/Shechterlab/PRMTsRegulatePostTranscriptionalDI.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Maron MI</collab><collab>Casill AD</collab><collab>Gupta V</collab><collab>Sidoli S</collab><collab>Query CC</collab><collab>Gamble MJ</collab><collab>Shechter D</collab></person-group><year iso-8601-date="2020">2020</year><source>Type I and II PRMTs Inversely Regulate Post-Transcriptional Intron Detention through Sm and CHTOP methylation</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163421">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163421</ext-link><comment>NCBI Gene Expression Omnibus, GSE163421</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-72867-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>